Soni Medicare Intrinsic Value
Soni Medicare intrinsic value. Soni Medicare (SML) median intrinsic value is ₹46.42 from 4 valuation models (range ₹14–₹58), vs current price ₹69.35 — -33.1% downside (Trading Above Calculated Value), margin of safety -49.4%. Compare with SML fair price to assess whether the stock is under or overvalued.
SML Valuation Methods Summary — DCF, Graham Number & P/E
Soni Medicare intrinsic value across 4 models vs current price ₹69.35 — upside/downside and value range per method. For current market price and key ratios, visit SML screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹13.87 | ₹12.48 - ₹15.26 | -80.0% | Book Value/Share: ₹2.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹58.00 | ₹52.20 - ₹63.80 | -16.4% | Revenue/Share: ₹72.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹27.74 | ₹24.97 - ₹30.51 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹46.42 | ₹37.14 - ₹55.70 | -33.1% | CF Growth: 5.0%, Discount: 15% |
SML Intrinsic Value vs Market Price — All Valuation Models
Soni Medicare fair value range ₹14–₹58 vs current market price ₹69.35 across 4 valuation models. Read SML dividend history for the complete payout history and dividend yield track record.
SML Intrinsic Value Analysis — Undervalued or Overvalued?
Soni Medicare median intrinsic value ₹46.42, current price ₹69.35 — Trading Above Calculated Value by 33.1%, margin of safety -49.4%.
What is the intrinsic value of SML?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Soni Medicare (SML) is ₹46.42 (median value). With the current market price of ₹69.35, this represents a -33.1% variance from our estimated fair value.
The valuation range spans from ₹13.87 to ₹58.00, indicating ₹13.87 - ₹58.00.
Is SML undervalued or overvalued?
Based on our multi-method analysis, Soni Medicare (SML) appears to be trading above calculated value by approximately 33.1%.
SML Financial Health — Key Ratios vs Industry Benchmarks
Soni Medicare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.27 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 22.00 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -100.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.32x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SML Cash Flow Quality — Operating & Free Cash Flow
Soni Medicare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-2 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |